NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols.

Glutamate cysteine ligase, the rate-limiting enzyme for the synthesis of glutathione, represents an important component of chemoprevention paradigms. GCLC and GCLM, the genes encoding glutamate cysteine ligase subunits, are induced by indoles, such as indomethacin. Novel functionalized indole analogues and other structurally related compounds were synthesized and used for a comparative structure analysis of GCLC induction. Use of mouse embryo fibroblasts null for Nrf2 (nuclear factor-erythroid 2p45-related transcription factor) and HepG2 cells overexpressing Keap1 demonstrated that indole analogue-mediated GCLC expression was regulated by Nrf2-Keap1 interactions. Indole analogues capable of inducing GCLC were found to increase NADPH oxidase activity. Indole analogues unable to induce GCLC did not increase oxidase activity. HepG2 cells transfected with FLAG/Keap1 were exposed to indomethacin, and the redox state of Keap1 cysteine residues was assessed. The data indicated that Keap1 exhibited several oxidation states that were sensitive to indomethacin treatment. These indomethacin-mediated changes in thiol oxidation states were suppressed by diphenyleneiodonium, a NADPH oxidase inhibitor. Diphenyleneiodonium also suppressed indole analogue-mediated increases in GCLC mRNA. In summary, the use of the indole analogues identified NADPH oxidase activity as a novel upstream activity regulating Nrf2/Keap1 signaling of GCLC, provided data supporting the hypothesis that Keap1 is a downstream effector for oxidase activity, and afforded in vivo data to support the hypothesis that Keap1 thiols can act as molecular sensors of reactive oxygen species. Finally, the comparative structure analysis suggests that 2-indol-3-yl-methylenequinuclidin-3-ols may represent a prototype for the development of novel chemopreventative agents able to activate Keap1/Nrf2 signaling.

[1]  Zhongmin Guo,et al.  Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Bokoch,et al.  Current molecular models for NADPH oxidase regulation by Rac GTPase. , 2002, Blood.

[3]  M. Freeman,et al.  Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2 , 2002, Oncogene.

[4]  L. Zipper,et al.  The Keap1 BTB/POZ Dimerization Function Is Required to Sequester Nrf2 in Cytoplasm* , 2002, The Journal of Biological Chemistry.

[5]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Wolf,et al.  Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. , 2002, The Biochemical journal.

[7]  A. Shah,et al.  Intracellular Localization and Preassembly of the NADPH Oxidase Complex in Cultured Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[8]  Xiaoqing Chang,et al.  Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity. , 2002, Mutation research.

[9]  J. French,et al.  Timing of Supplementation With the Antioxidant N-Acetyl-L-Cysteine Reduces Tumor Multiplicity in Novel, Cancer-Prone p53 Haploinsufficient Tg.AC (v-Ha-ras) Transgenic Mice but Has No Impact on Malignant Progression , 2002, Nutrition and cancer.

[10]  L. Marnett,et al.  Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. , 2002, Free radical biology & medicine.

[11]  M. Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[12]  P. Krammer,et al.  Glutathione Dependence of Caspase-8 Activation at the Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[13]  S. De Flora,et al.  Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  O. Fardel,et al.  Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. , 2002, Biochemical pharmacology.

[15]  J. Lambeth.  Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases , 2002, Current opinion in hematology.

[16]  H. Pinedo,et al.  Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor Arsenite* , 2001, The Journal of Biological Chemistry.

[17]  S. De Flora,et al.  Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. , 2001, Cancer research.

[18]  S. Nomoto,et al.  Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. , 2001, Cancer research.

[19]  S. Dhakshinamoorthy,et al.  Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene , 2001, Oncogene.

[20]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[21]  C. Wolf,et al.  The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. , 2001, Cancer research.

[22]  M. Massiah,et al.  Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Wolf.  Chemoprevention: Increased potential to bear fruit , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Matthew Davison,et al.  Validation and development of fluorescence two‐dimensional differential gel electrophoresis proteomics technology , 2001, Proteomics.

[25]  T. Yamakawa,et al.  Mechanism of superoxide generation system in indomethacin-induced gastric mucosal injury in rats. , 2001, Biological & pharmaceutical bulletin.

[26]  J. Chan,et al.  Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. , 2000, Biochimica et biophysica acta.

[27]  M. Fukumoto,et al.  NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. , 2000, Gene.

[28]  R. Mulcahy,et al.  Regulation of γ-Glutamylcysteine Synthetase Subunit Gene Expression by the Transcription Factor Nrf2* , 1999, The Journal of Biological Chemistry.

[29]  Wild Ac,et al.  Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. , 1999 .

[30]  R Fauchet,et al.  Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity. , 1999, International journal of oncology.

[31]  C. Ross,et al.  PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Y. Kan,et al.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. De Flora,et al.  Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. , 1991, The American journal of medicine.

[34]  A. Meister.  Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.

[35]  T. Slaga,et al.  Effect of exogenous glutathione on tumor progression in the murine skin multistage carcinogenesis model. , 1988, Carcinogenesis.

[36]  D. J. Reed,et al.  Characterization of glutathione-dependent inhibition of lipid peroxidation of isolated rat liver nuclei. , 1988, Archives of biochemistry and biophysics.

[37]  J. A. Thomas,et al.  A thin-gel isoelectric focusing method for quantitation of protein S-thiolation. , 1986, Analytical biochemistry.

[38]  M. Owen,et al.  Inhibitory effects of glutathione level-raising agents and D-alpha-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. , 1985, Carcinogenesis.

[39]  D. J. Reed,et al.  Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). , 1983, Biochemical pharmacology.

[40]  D. J. Reed,et al.  Status of the mitochondrial pool of glutathione in the isolated hepatocyte. , 1982, The Journal of biological chemistry.

[41]  M. Wolin,et al.  Oxidant Signalling and Vascular Oxygen Sensing , 2002 .

[42]  M. Kwak,et al.  Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. , 2001, Molecular medicine.

[43]  M. Wolin,et al.  Oxidant signalling and vascular oxygen sensing. Role of H2O2 in responses of the bovine pulmonary artery to changes in PO2. , 2000, Advances in experimental medicine and biology.

[44]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.